Mizuho sees Sarepta Therapeutics (SRPT) sell-off on elevidys death 'likely an overreaction'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 19.01 +0.47 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.54 | 52 Week High | $63.73 | |||
| Open | $18.94 | 52 Week Low | $8.00 | |||
| Day High | $19.20 | P/E | N/A | |||
| Day Low | $18.80 | EPS | $-5.69 | |||
| Volume | 81,118 | |||||
